Second Sight Medical Products, Inc.

NasdaqCM:EYES Stock Report

Market Cap: US$54.4m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Second Sight Medical Products Management

Management criteria checks 3/4

Key information

Scott Dunbar

Chief executive officer

US$301.4k

Total compensation

CEO salary percentage77.8%
CEO tenure1.4yrs
CEO ownership0.006%
Management average tenureno data
Board average tenure7.1yrs

Recent management updates

Recent updates

Second Sight, Nano Precision complete merger, renaming as Vivani Medical

Aug 30

Second Sight Medical sheds ~17% after reverse stock split

Aug 19

Second Sight stock rises as shareholders approve merger, name change, reverse stock split

Jul 29

Second Sight stock rises ~10% on $1.1M funding from NIH for artificial vision implant trial

Jul 18

Revisiting Second Sight Medical Products: The EV Is Negative And Being Short No Longer Looks Appealing

Mar 22

Second Sight Medical rises defying legal battle; regains NASDAQ compliance

Jun 04

CEO Compensation Analysis

How has Scott Dunbar's remuneration changed compared to Second Sight Medical Products's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2022n/an/a

-US$9m

Mar 31 2022n/an/a

-US$8m

Dec 31 2021US$301kUS$235k

-US$9m

Sep 30 2021n/an/a

-US$9m

Jun 30 2021n/an/a

-US$8m

Mar 31 2021n/an/a

-US$9m

Dec 31 2020US$342kUS$255k

-US$15m

Compensation vs Market: Scott's total compensation ($USD301.39K) is below average for companies of similar size in the US market ($USD764.69K).

Compensation vs Earnings: Scott's compensation has been consistent with company performance over the past year.


CEO

Scott Dunbar (64 yo)

1.4yrs

Tenure

US$301,389

Compensation

Mr. Scott Dunbar has been Acting Chief Executive Officer at Second Sight Medical Products, Inc since March 26, 2021. For many years he served Second Sight as Patent Counsel, Senior Patent Counsel, and Seni...


Board Members

NamePositionTenureCompensationOwnership
Matthew Pfeffer
Independent Director7.3yrsUS$55.00k0.038%
$ 20.4k
Aaron Mendelsohn
Independent Director24.6yrsUS$59.00k0%
$ 0
Gregg Williams
Independent Non-Executive Chairman13.2yrsUS$54.00k19.28%
$ 10.5m
Jonathan McGuire
Director7yrsUS$35.00k0.052%
$ 28.2k
Dean Baker
Independent Director1.3yrsUS$59.00kno data
Alexandra Larson
Independent Director1.3yrsUS$35.00k0.0013%
$ 690.7

7.1yrs

Average Tenure

63.5yo

Average Age

Experienced Board: EYES's board of directors are considered experienced (7.1 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.